In particular, RKIP has been reported to contribute to the control of the immune cell infiltration in the tumor microenvironment, in the regulation of host anti-tumor immune-surveillance and responses to immunotherapy, as well as in the modulation of inflammatory processes and the outcome of associated diseases [181]. This evidence concerns the gene PEBP1 and neoplasm.